Skip to main content
Premium Trial:

Request an Annual Quote

Vysis Introduces DNA Probes for Identifying Genetic Abnormalities


DOWNERS GROVE, Ill.--Vysis announced the availability of its first group of TelVysion DNA probes for the detection of genetic abnormalities involving telomeres for prenatal, congenital, and cancer research. The probes utilize Vysis's fluorescence in situ hybridization (FISH) technology to visually detect translocations associated with disease. The probes were developed in connection with a research and exclusive license agreement with the University of Chicago. The complete line of Vysis's TelVysion FISH probes will consist of 82 products, with 41 probes specific to telomeric regions of each human chromosome.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.